Multiple small pulmonary emboli associated with transient antiphospholipid syndrome in human Parvovirus B19 infection
Authors:
- 19 January 2006
- journal article
- case report
- Published by Springer Nature in Clinical Rheumatology
- Vol. 25 (4) , 585-587
Abstract
Antiphospholipid antibodies (aPL) have been reported to occur in several conditions other than antiphospholipid syndrome, including infections. We herein report the case of a 21-year-old Japanese woman with Parvovirus B19 infection, who developed multiple pulmonary emboli associated with aPL, a lupus anticoagulant and IgM anticardiolipin antibody. Eight weeks later, antiphospholipid antibodies spontaneously disappeared and normal pulmonary flow was observed. Considering the high prevalence of Parvovirus B19 infection, we should be aware of thrombosis associated with transient aPL antibodies in this infectious disease.Keywords
This publication has 10 references indexed in Scilit:
- Parvovirus B19 infection and autoimmune diseaseAutoimmunity Reviews, 2003
- Viral infections and antiphospholipid antibodiesSeminars in Arthritis and Rheumatism, 2002
- Transient anticardiolipin antibody syndrome in a patient with parvovirus b19 infectionThe American Journal of Medicine, 2000
- High prevalence of anticardiolipin antibodies in hepatitis C virus infection: lack of effects on thrombocytopenia and thrombotic complicationsJournal of Gastroenterology, 2000
- Anticardiolipin Antibodies in Patients with Chronic Hepatitis C Virus Infection: Characterization in Relation to Antiphospholipid SyndromeClinical and Diagnostic Laboratory Immunology, 2000
- Is there a phospholipid specificity of lupus anticoagulants (LAC) in patients with autoimmune and drug induced LAC?1998
- Association between IgM anticardiolipin antibodies and deep venous thrombosis in patients without systemic lupus erythematosusLupus, 1997
- Prevalence and clinical significance of anticardiolipin antibodies in pregnancies complicated by parvovirus B19 infectionPrenatal Diagnosis, 1995
- Clinical manifestations of the antiphospholipid syndrome in patients with systemic lupus erythematosus associate more strongly with anti-beta 2-glycoprotein-I than with antiphospholipid antibodies.1995
- Anticoagulant Activity of β2-Glycoprotein I Is Potentiated by a Distinct Subgroup of Anticardiolipin AntibodiesThrombosis and Haemostasis, 1992